AbbVie (ABBV) sues Trump administration to narrow drug discount patient definition, via Axios

AbbVie's lawsuit against the Trump administration to narrow the drug discount patient definition could have significant implications for pharmaceutical pricing policies.

Newsquawk StaffPublished On the live feed at 8 more headlines followed before this page went public
Newsquawk headlinesUTC

US President Trump says numerous agreements, lists and letters are being sent out by people who have nothing to do with US/Iran negotiations; there is only one group of points acceptable to the US, will be discussing them behind closed doors

Meta (META) introduces Muse Spark, a natively multimodal reasoning model

AbbVie (ABBV) sues Trump administration to narrow drug discount patient definition, via Axios

Iran Foreign Minister in Call with Turkish Foreign Minister says Iran accepted the ceasefire as a basis for a complete end of the war; Iran agreed to the ceasefire based on its ten point plan as a basis for talks with the US

Al Arabiya correspondent reports new Israeli airstrikes on Beirut

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

If successful, this move may impact how drug discounts are applied, potentially affecting the company's revenue and broader industry practices. Traders should consider the regulatory risks and cost structures in biotech, as well as potential ripple effects on other players in the sector.

Related headlines

The whole workspace, free to try.

Try it free